They'll Always Be Your Babies.
Make Sure Your Teen Gets a Second Shot to Help Prevent Meningitis.1
What Is Meningococcal Meningitis?
Meningococcal meningitis is a bacterial infection that results in inflammation of the lining of the brain and spinal cord, which can cause severe illness and even death in less than 24 hours.2-4 Teenagers are at increased risk for the disease and can suffer devastating consequences.3,5,6 Of the 800 to 1200 cases of meningococcal disease in the US each year, 10-15% are fatal.5,7-9
In 24 Hours, Meningococcal Meningitis Can Have Devastating Consequences2-4,10
About 1 in 5 people who survive meningococcal meningitis can suffer permanent complications such as3,6,11:
- Amputation of limbs, fingers, or toes
- Severe scarring
- Brain damage
- Hearing loss
- Kidney damage
Meningococcal Meningitis Is Contagious
The bacteria that cause meningococcal meningitis can be spread through the exchange of oral secretions (saliva) during common activities; such as2,5,12,13:
- Sharing utensils and drinking glasses
Risk factors for meningococcal meningitis include:
- Living in close quarters (ie, dormitories)
- Smoking or being exposed to smoke
Protect Your Teen With a Meningitis Booster Shot
Millions of teens are under-protected.14-16 That's why the Centers for Disease Control and Prevention (CDC) recommends a meningitis booster shot at 16 to 18 years of age.1 Even if your teen already received a meningitis shot at age 11 or 12 years, he or she still needs a second vaccination as early as 16 years of age.1
"I'd hate for someone to go through what I had to go through."
Bob and Dee Dee's Story
"She started feeling sick on Tuesday, and by Wednesday she was gone."
- Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older—United States, 2013. MMWR. 2013a;62(suppl):1-19.
- Apicella MA. Neisseria meningitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier;2010;2737-2752.
- Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33(5):737-739.
- Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.
- Atkinson W, Wolfe S, Hamborsky J, McIntyre L, eds. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 12th ed. Washington DC: Public Health Foundation; 2011.
- Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123(3):e502-e509.
- CDC. Prevention and Control of Meningococcal Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013b;62(2):1-32.
- CDC. Notifiable diseases and mortality tables [provisional]—week ending December 29, 2012. MMWR. 2013c;61(51 & 52):ND-719-ND-732.
- Thigpen MC, Whitney CG, Messonnier NE, et al; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016-2025.
- Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369(9580):2196-2210.
- Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Clin Infect Dis. 1998;26(5):1159-1164.
- Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA. 2001;286(6):688-693.
- MacLennan J, Kafatos G, Neal K, et al; United Kingdom Meningococcal Carriage Group. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12(6):950-957.
- CDC. Updated Recommendations for Use of Meningococcal Conjugate Vaccines — Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2011;60(3):72-76.
- Sanofi Pasteur Inc. Data on file (2nd dose immunization rates), April 2013. MKT26442
- United Stated Census Bureau. Age and Sex Composition: 2010. Washington, DC. U.S. Department of Commerce; 2011.